Insiders · Profile

Zakrzewski Joseph S

Director at AN2 Therapeutics · Director at AMARIN CORP PLC\UK · Director at Insulet. Filing since 11 Nov 2008. CIK 0001331852

Company
Date
Role
Action
Shares
Amount
Of holding
27 Nov 2024
Director
Bought
2,000
$2.80K
1.6%
19 Nov 2024
Director
Bought
5,000
$5.05K
4.2%
18 Nov 2024
Director
Bought
20,000
$20.00K
20.4%
18 Jan 2024
Director
Sold at will
100,000
$1.91M
19.8%
15 Dec 2021
Director
Bought
2,000
$6.31K
1.0%
14 Dec 2021
Director
Bought
10,000
$32.69K
5.4%
3 Jan 2020
Director
Sold, plan not stated
300,000
$6.28M
78.0%
16 Dec 2019
Director
Sold, plan not stated
100,000
$2.58M
54.2%
5 Jul 2019
Director
Sold, plan not stated
100,000
$2.38M
54.2%
18 Jun 2019
Director
Sold, plan not stated
100,000
$1.90M
54.2%
22 Feb 2019
Director
Sold, plan not stated
180,625
$3.59M
68.1%
10 Jan 2019
Director
Sold, plan not stated
200,000
$3.40M
70.3%
2 Jan 2019
Director
Sold, plan not stated
385,000
$5.02M
82.0%
28 Dec 2018
Director
Sold, plan not stated
141,500
$1.87M
62.6%
24 Sep 2018
Director
Sold, plan not stated
500,000
$5.30M
68.9%
2 Mar 2017
Director
Sold, plan not stated
40,000
$1.87M
59.0%
18 Nov 2013
Chief Executive Officer
Bought
50,777
$78.20K
29.0%
1 Oct 2012
Chief Executive Officer
Sold, plan not stated
150,000
$1.88M
57.3%
27 Jul 2012
Chief Executive Officer
Sold, plan not stated
150,000
$2.15M
57.3%
29 May 2012
Chief Executive Officer
Sold, plan not stated
150,000
$1.80M
65.6%
23 Mar 2012
Chief Executive Officer
Sold, plan not stated
160,000
$1.85M
67.1%
17 Feb 2012
Director
Sold, plan not stated
3,000
$60.59K
27.3%
16 Feb 2012
Director
Sold, plan not stated
2,000
$41.34K
15.4%
18 Apr 2011
Chief Executive Officer
Sold, plan not stated
300,000
$4.73M
82.5%
25 Feb 2011
Chief Executive Officer
Sold, plan not stated
60,000
$489.76K
52.8%
22 Feb 2011
Chief Executive Officer
Sold, plan not stated
100,000
$854.06K
65.1%
11 Nov 2008
Director
Bought
5,000
$23.55K
opened
27 decisions on file.